The firm, set to play a key role in the manufacture of four leading COVID-19 vaccine candidates, has been caught selling the US government a biodefense product it knew was non-functional.
The firm knew that Trobigard’s functionality and safety in humans had never been tested months before it was awarded a no-bid $25 million contract in 2017.
naturalblaze.com
Get replies from creators like Joychrish
